NCT06956495View on ClinicalTrials.gov

Efficacy and Tolerability of Tasipimidine in Sleepless Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

190

Participants

Timeline

Start Date

August 20, 2023

Primary Completion Date

September 11, 2025

Study Completion Date

September 24, 2025

Conditions

Insomnia

Interventions

DRUG

Tasipimidine

Tasipimidine solution

DRUG

Tasipimidine placebo

Tasipimidine placebo solution

Trial Locations (1)

00380

Terveystalo Helsinki Uniklinikka, Helsinki

Sponsors

Collaborators (1)

ICON Clinical Research

All Listed Sponsors

collaborator

ICON Clinical Research

INDUSTRY

lead

Orion Corporation, Orion Pharma

INDUSTRY